Healthcare software provider Veeva Systems (NASDAQ:VEEV) will be reporting earnings tomorrow after market close. Here's what to expect.

Last quarter Veeva Systems reported revenues of $616.5 million, up 11.6% year on year, in line with analyst expectations. It was a weaker quarter for the company, with and underwhelming revenue guidance for the next quarter.

Is Veeva Systems buy or sell heading into the earnings? Read our full analysis here, it's free.

This quarter analysts are expecting Veeva Systems's revenue to grow 10.2% year on year to $621.1 million, slowing down from the 16% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.30 per share.

Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company has a history of exceeding Wall St's expectations, beating revenue estimates every single time over the past two years on average by 1.2%.

Looking at Veeva Systems's peers in the vertical software segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. Doximity delivered top-line growth of 17.4% year on year, beating analyst estimates by 6.1% and ANSYS reported revenues up 16% year on year, exceeding estimates by 1.2%. Doximity traded down 10.1% on the results, and ANSYS was up 1.3%.

Read our full analysis of Doximity's results here and ANSYS's results here.

Investors in the vertical software segment have had steady hands going into the earnings, with the stocks up on average 0.8% over the last month. Veeva Systems is up 5.8% during the same time, and is heading into the earnings with analyst price target of $217, compared to share price of $223.1.

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.